In addition, several circRNAs contribute to the resistance of cancer cells to apatinib, a selective inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2), which also exhibits anti-tumor activity in solid tumors [90]. The gene discussed is KDR; the disease is cancer.